These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 16048445
1. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Yen CF, Chen CS, Ko CH, Yeh ML, Yang SJ, Yen JY, Huang CF, Wu CC. Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445 [Abstract] [Full Text] [Related]
2. [Relationships between insight and medication adherence in subjects with psychosis]. Droulout T, Liraud F, Verdoux H. Encephale; 2003 Aug; 29(5):430-7. PubMed ID: 14615692 [Abstract] [Full Text] [Related]
4. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission. Yen CF, Cheng CP, Huang CF, Yen JY, Ko CH, Chen CS. Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246 [Abstract] [Full Text] [Related]
5. Changes of insight in manic episodes and influencing factors. Yen CF, Chen CS, Yeh ML, Yang SJ, Ke JH, Yen JY. Compr Psychiatry; 2003 Jul; 44(5):404-8. PubMed ID: 14505301 [Abstract] [Full Text] [Related]
7. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study. Yen CF, Chen CS, Yen JY, Ko CH. J Affect Disord; 2008 May; 108(1-2):121-7. PubMed ID: 17997489 [Abstract] [Full Text] [Related]
8. Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder. Yen CF, Chen CC, Cheng CP, Yen CN, Lin HC, Ko CH, Yen JY, Chen CS. Psychiatry Clin Neurosci; 2008 Dec; 62(6):685-90. PubMed ID: 19068005 [Abstract] [Full Text] [Related]
9. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence. Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman J, Schene A, Nosè M, Helm H, Thornicroft G, Tansella M. Psychopathology; 2009 Dec; 42(5):311-7. PubMed ID: 19672133 [Abstract] [Full Text] [Related]
11. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up. de Haan L, van Amelsvoort T, Dingemans P, Linszen D. Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650 [Abstract] [Full Text] [Related]
12. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C. Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012 [Abstract] [Full Text] [Related]
15. Relationship between insight and neurocognition in patients with bipolar I disorder in remission. Yen CF, Cheng CP, Ko CH, Yen JY, Huang CF, Chen CS. Compr Psychiatry; 2008 Jul; 49(4):335-9. PubMed ID: 18555052 [Abstract] [Full Text] [Related]
16. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gómez-Beneyto M, Vieta E. J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698 [Abstract] [Full Text] [Related]
17. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP, Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. J Clin Psychiatry; 2009 Aug; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636 [Abstract] [Full Text] [Related]